The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity
YA Zabrodskaya, DV Lebedev, MA Egorova… - Biophysical …, 2018 - Elsevier
The influenza virus polymerase complex is a promising target for new antiviral drug
development. It is known that, within the influenza virus polymerase complex, the PB1
subunit region from the 1st to the 25th amino acid residues has to be is in an alpha-helical …
development. It is known that, within the influenza virus polymerase complex, the PB1
subunit region from the 1st to the 25th amino acid residues has to be is in an alpha-helical …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论